SPIA
AMED

Steward Partners Investment Advisory’s Amedisys AMED Stock Holding History

Steward Partners Investment Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-114
Closed -$11K – 3973
2024
Q3 		$11K Hold
114
– – ﹤0.01% 2915
2024
Q2 		$10.5K Buy
114
+14
+14% +$1.3K ﹤0.01% 2803
2024
Q1 		$9.22K Hold
100
– – ﹤0.01% 2842
2023
Q4 		$9.51K Hold
100
– – ﹤0.01% 2734
2023
Q3 		$9.34K Hold
100
– – ﹤0.01% 2624
2023
Q2 		$9.14K Hold
100
– – ﹤0.01% 2598
2023
Q1 		$7.36K Hold
100
– – ﹤0.01% 2657
2022
Q4 		$8.35K Hold
100
– – ﹤0.01% 2597
2022
Q3 		$10K Sell
100
-13
-12% -$1.55K ﹤0.01% 2517
2022
Q2 		$12K Buy
113
+3
+3% +$383 ﹤0.01% 2434
2022
Q1 		$19K Buy
110
+55
+100% +$8.22K ﹤0.01% 2383
2021
Q4 		$9K Hold
55
– – ﹤0.01% 2626
2021
Q3 		$8K Hold
55
– – ﹤0.01% 2661
2021
Q2 		$13K Hold
55
– – ﹤0.01% 5639
2021
Q1 		$14.6K Hold
55
– – ﹤0.01% 2619
2020
Q4 		$16K Hold
55
– – ﹤0.01% 2129
2020
Q3 		$13K Hold
55
– – ﹤0.01% 2030
2020
Q2 		$11K Buy
+55
New +$10.3K ﹤0.01% 1990

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Steward Partners Investment Advisory's AMED Position: Q4 2024 in Review

Steward Partners Investment Advisory sold out of Amedisys (AMED) in Q4 2024, closing a stake of 114 shares — an estimated $11K sold.

Steward Partners Investment Advisory first reported a position in AMED in Q2 2020 and held it in 18 quarters. The position peaked at $19K in Q1 2022. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Steward Partners Investment Advisory reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 114 Amedisys shares in Q4 2024, an estimated $11K.
  • Steward Partners Investment Advisory first reported a position in Amedisys in Q2 2020 and held it in 18 quarters.
  • Steward Partners Investment Advisory's Amedisys position peaked at $19K in Q1 2022.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2024, filed 6 Feb 2025.